Kargi Ahmet Bulent
Department of Thoracic Surgery, Medical Park Hospital, Antalya, Turkey.
Thorac Cardiovasc Surg. 2017 Sep;65(6):479-483. doi: 10.1055/s-0036-1579680. Epub 2016 Apr 4.
Hyperhidrosis is a dysfunction of the autonomic nervous system that results in regional excessive sweating, mostly in the hands, armpits, and feet. A permanent and effective treatment of hyperhidrosis can be achieved by interruption of the thoracic sympathetic chain with endoscopic thoracic sympathectomy (ETS). However, some side effects, particularly compensatory sweating (CS), are the limitations of this procedure. The mechanism of CS and the associated risk factors are still controversial. The aim of this retrospective study was to determine the relationship with various parameters associated with CS in patients undergoing ETS. ETS was performed on a total of 95 patients for palmar hyperhidrosis, axillary hyperhidrosis and facial blushing by the same surgeon. The mean age of the patients was 26.41 (± 7) years, and 54 (56.8%) were males. Palmar hyperhidrosis was present in 54 (56.8%) patients, axillary hyperhidrosis in 33 (34.7%) patients, and facial blushing in 8 (8.5%) patients. Moreover, 38 (40%) patients also had plantar sweating. The severity of CS was rated into three scales as less, moderate, and severe. Regarding the severity of CS, 55 (57.9%) patients had no or less CS, 28 (29.5%) had moderate CS, and 12 (12.6%) patients had severe CS. Higher age group had a significant increased risk of severe CS ( = 0.03) ( = 0.262). Patients with body mass index (BMI) > 25 kg/m had a statistically significantly increased risk of severe CS ( = 0.016). Facial blushing resulted in severe CS in a significantly higher proportion of patients than by palmar and axillary hyperhidrosis ( = 0.001). The level of surgery was another important risk factor for CS, with the T2 level showing an increased risk of severe CS compared with T3 level ( < 0.001). Furthermore, plantar sweating was inversely and significantly related to the development of CS. Patients with plantar sweating had a significantly decreased incidence of developing CS ( = 0.015). CS after thoracic sympathectomy for primary hyperhidrosis is the most displeasing and restrictive side effect. This study demonstrates that older age, operation level, facial blushing, and high BMI are risk factors for CS, as have been shown in several similar studies. An interesting finding of the present study is that there was a decreased incidence of CS among patients with plantar sweating. This situation may help us to distinguish high risk for CS before ETS operation.
多汗症是一种自主神经系统功能障碍,会导致局部多汗,主要出现在手部、腋窝和足部。通过内镜胸交感神经切除术(ETS)切断胸交感神经链可实现对多汗症的永久性有效治疗。然而,一些副作用,尤其是代偿性出汗(CS),是该手术的局限性。CS的机制及相关危险因素仍存在争议。这项回顾性研究的目的是确定接受ETS治疗的患者中与CS相关的各种参数之间的关系。
共有95例患者因手掌多汗症、腋窝多汗症和面部潮红接受了同一位外科医生的ETS治疗。患者的平均年龄为26.41(±7)岁,其中54例(56.8%)为男性。54例(56.8%)患者有手掌多汗症,33例(34.7%)患者有腋窝多汗症,8例(8.5%)患者有面部潮红。此外,38例(40%)患者也有足底出汗。CS的严重程度分为轻度、中度和重度三个等级。
关于CS的严重程度,55例(57.9%)患者无或有轻度CS,28例(29.5%)有中度CS,12例(12.6%)患者有重度CS。年龄较大的组发生重度CS的风险显著增加(P = 0.03)(OR = 0.262)。体重指数(BMI)>25 kg/m²的患者发生重度CS的风险在统计学上显著增加(P = 0.016)。面部潮红导致重度CS的患者比例显著高于手掌和腋窝多汗症患者(P = 0.001)。手术水平是CS的另一个重要危险因素,与T3水平相比,T2水平发生重度CS的风险增加(P < 0.001)。此外,足底出汗与CS的发生呈负相关且具有显著相关性。有足底出汗的患者发生CS的发生率显著降低(P = 0.015)。
原发性多汗症胸交感神经切除术后的CS是最令人不快和受限的副作用。本研究表明,年龄较大、手术水平、面部潮红和高BMI是CS的危险因素,这在几项类似研究中也已得到证实。本研究的一个有趣发现是,有足底出汗的患者中CS的发生率降低。这种情况可能有助于我们在ETS手术前区分CS的高风险患者。